GR3001098T3 - Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes - Google Patents

Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes

Info

Publication number
GR3001098T3
GR3001098T3 GR90400840T GR900400840T GR3001098T3 GR 3001098 T3 GR3001098 T3 GR 3001098T3 GR 90400840 T GR90400840 T GR 90400840T GR 900400840 T GR900400840 T GR 900400840T GR 3001098 T3 GR3001098 T3 GR 3001098T3
Authority
GR
Greece
Prior art keywords
human
preparation
treatment
chelating
propylmethylcellulose
Prior art date
Application number
GR90400840T
Other languages
English (en)
Inventor
Shambhu Dayal Varma
Original Assignee
Vision Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25417752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3001098(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vision Pharma Inc filed Critical Vision Pharma Inc
Publication of GR3001098T3 publication Critical patent/GR3001098T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
GR90400840T 1986-09-04 1990-11-23 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes GR3001098T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/903,597 US5032392A (en) 1986-09-04 1986-09-04 Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes

Publications (1)

Publication Number Publication Date
GR3001098T3 true GR3001098T3 (en) 1992-04-17

Family

ID=25417752

Family Applications (2)

Application Number Title Priority Date Filing Date
GR90400840T GR3001098T3 (en) 1986-09-04 1990-11-23 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
GR950400201T GR3014937T3 (en) 1986-09-04 1995-02-01 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes.

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR950400201T GR3014937T3 (en) 1986-09-04 1995-02-01 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes.

Country Status (9)

Country Link
US (1) US5032392A (el)
EP (1) EP0258865B2 (el)
JP (1) JPH0751500B2 (el)
AT (1) ATE58475T1 (el)
AU (1) AU599695B2 (el)
CA (1) CA1341393C (el)
DE (1) DE3766322D1 (el)
GR (2) GR3001098T3 (el)
IN (1) IN165608B (el)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
DE69116010T2 (de) * 1990-06-29 1996-05-30 Santen Pharmaceutical Co Ltd Verwendung einer Zusammensetzung zur Herstellung eines Medicamentes zur Entfernung der Reste von Linsenmaterialien
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
WO1993021903A1 (en) * 1992-05-06 1993-11-11 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
US5830508A (en) 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
KR100338851B1 (ko) * 1994-03-15 2002-10-12 센주 세이야꾸 가부시키가이샤 프라노프로펜의안정화방법및안정한프라노프로펜약제
KR970705985A (ko) * 1994-09-14 1997-11-03 우에하라 아끼라 각막 장해 복구용 점안제(Eye Drops for Repairing Corneal Disturbance)
US6113894A (en) * 1995-01-23 2000-09-05 Smith; S. Gregory Ophthalmic compositions and process of using
US5861148A (en) * 1995-01-23 1999-01-19 Smith; Stewart Gregory Ophthalmic compositions and process of using
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5783407A (en) * 1996-04-05 1998-07-21 Beckman Instruments, Inc. Method of measuring bilirubin
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US6726922B1 (en) 1999-06-28 2004-04-27 Minu, L.L.C. Process and composition for temporarily suppressing pain
JP2001158734A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
JP4713706B2 (ja) * 2000-03-14 2011-06-29 テルモ株式会社 脂溶性ビタミン可溶化液入り容器
KR20030026973A (ko) * 2000-07-12 2003-04-03 로그 밸리 내츄럴 스프링즈 인코포레이티드 안구 표면에 습기를 공급하기 위한 방법 및 키트
US7524511B1 (en) * 2000-07-12 2009-04-28 Rogue Valley Natural Springs, Inc. Method and kit for moisturizing the surface of the eye
EP1207208A3 (en) * 2000-11-15 2003-12-10 Becton Dickinson and Company Method for preservation of cells and nucleic acid targets
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
AU2002232487A1 (en) 2000-12-19 2002-07-01 Bausch And Lomb Incorporated Method for enhancing integrity of epithelium using retinoic acid
SE520715C2 (sv) * 2001-12-03 2003-08-12 Akzo Nobel Nv Förfarande för framställning av metylcellulosaetrar
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
EP1807103A4 (en) 2004-11-04 2009-02-11 Sirion Therapeutics Inc MODULATORS OF A COMPLEX RETINOL-RETINOL-BINDING PROTEIN-TRANSTHYRETINE FORMATION
JP5179381B2 (ja) * 2006-02-17 2013-04-10 ノバルティス アーゲー ヒドロゲルコンタクトレンズの滅菌方法
WO2008137496A1 (en) * 2007-05-04 2008-11-13 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
US10383839B2 (en) 2011-06-30 2019-08-20 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
JP6179204B2 (ja) * 2012-06-08 2017-08-16 ライオン株式会社 粘膜用組成物及びその製造方法
KR102243169B1 (ko) 2013-01-23 2021-04-22 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
AU2014212275B2 (en) 2013-02-01 2018-09-06 Ocuphire Pharma, Inc. Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
PT2950648T (pt) 2013-02-01 2020-01-06 Ocuphire Pharma Inc Soluções oftálmicas aquosas de fentolamina e usos médicos
ES2669446B1 (es) * 2016-11-24 2019-03-13 Saiz Manuel Munoz Producto oftálmico
KR20200081402A (ko) * 2017-11-24 2020-07-07 주식회사 지트리비앤티 티모신 베타 4 또는 이의 유도체를 유효성분으로 포함하는 술잔세포 증식 또는 뮤신 분비 촉진용 조성물
MX2021004708A (es) 2018-10-26 2021-11-03 Ocuphire Pharma Inc Metodos y composiciones para tratamiento de presbicia, midriasis y otros trastornos oculares.
WO2020198064A1 (en) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384545A (en) * 1965-03-09 1968-05-21 Hoffmann La Roche Injectable aqueous emulsions of fat soluble vitamins
GB1431841A (en) * 1973-01-15 1976-04-14 Evans S C Ophthalmic-nutritional preparations
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4515794A (en) * 1981-10-09 1985-05-07 Baylor College Of Medicine Mitotic inhibitors preventing posterior lens capsule opacification
ZA827364B (en) * 1981-10-09 1983-09-28 Baylor College Medicine Methods of preventing proliferation of remnant lens epithelial cells
US4421748A (en) * 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid

Also Published As

Publication number Publication date
EP0258865A3 (en) 1989-03-08
AU7797887A (en) 1988-03-10
JPS63208516A (ja) 1988-08-30
IN165608B (el) 1989-11-25
CA1341393C (en) 2002-10-15
EP0258865B1 (en) 1990-11-22
EP0258865A2 (en) 1988-03-09
GR3014937T3 (en) 1995-05-31
US5032392A (en) 1991-07-16
EP0258865B2 (en) 1995-01-04
DE3766322D1 (de) 1991-01-03
JPH0751500B2 (ja) 1995-06-05
AU599695B2 (en) 1990-07-26
ATE58475T1 (de) 1990-12-15

Similar Documents

Publication Publication Date Title
GR3001098T3 (en) Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US5585406A (en) Nonirritating nonionic tissue cleaning method
EP0246652A3 (en) Aqueous steroid formulations for nasal administration
KR100260061B1 (en) Vitamin e drop
HU900591D0 (en) Regulated agent-dissolving safety system and process of it's preparation
JPH11199899A (ja) コンタクトレンズ用液およびそれを用いたコンタクトレンズの洗浄方法
WO1991015200A3 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
FR2833493B1 (fr) Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
JP2002524418A (ja) 眼用組成物および使用法
EP0255967B1 (en) Method of treating contact lenses
IE821566L (en) Composition for topical application to skin
US4692262A (en) Skin cleanser capable of softening and removing smegma
JPS6442424A (en) Ophthalmic solution
ES2073245T3 (es) Agentes para el tratamiento de la cornea.
DK0741579T3 (da) Vandig formulering med forhalet frigivelse
JPS568324A (en) Infectious disease remedy for external and ophthalmologic application
Kawai et al. The Influence of surfactants upon the skin IV The influence of Sodium Lauryl Sulfate upon the skin
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases
GR3018349T3 (en) Use of naproxen as mydriatic agent.
ES512751A0 (es) "procedimiento para la preparacion de un colirio antiseptico para afecciones oculares".
DE69001238T2 (de) Neues Arzneimittel mit antiallergischer Wirkung und verzögerter Wirkstofffreigabe.
JO1317B1 (en) Eye treatment